A gel with tiny particles for diabetic dry eye disease
Treatments studied
Part of Eyes & vision clinical trials.
This trial tests a special gel containing small particles that may help repair the eye's surface. It is for people with diabetes who also have severe dry eye symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have diabetes, with high blood sugar levels confirmed by a recent test.
- You have had severe dry eye symptoms (like dryness, burning, or blurry vision) in both eyes for at least 6 months.
- You regularly use artificial tears for your dry eyes.
- You are not planning to become pregnant or father a child during the study and for 90 days after.
- You must not have certain eye problems, like recent surgery, active infections, or other serious eye conditions listed by the doctors.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests whether special cells derived from umbilical cord tissue can help treat dry eye disease. The treatment uses tiny particles called extracellular vesicles that may reduce eye dryness and improve comfort.
This trial tests a new eye drop gel (CsA-PG) for people with dry eye disease. Participants must have had dry eyes for at least 6 months and meet specific eye exam scores. The study checks if the gel can improve symptoms and eye health.
This trial tests an exosome treatment for people with Sjögren's syndrome whose dry eye symptoms haven't improved with standard care like artificial tears or steroid drops. The goal is to see if this new approach can help relieve eye discomfort.
This trial tests a new eye drop made from stem cells to see if it can help relieve dry eye symptoms. It is for people with moderate to severe dry eye who haven't had recent eye surgery or used other eye drops.
This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.
This trial tests an eye drop solution for people with chronic dry eye caused by graft-versus-host disease after a stem cell transplant. It aims to see if the drops can reduce eye discomfort and improve the eye surface.
Hear when a new Diabetic Keratopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.